Sarah E. DeRossett

518 total citations
18 papers, 398 citations indexed

About

Sarah E. DeRossett is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Sarah E. DeRossett has authored 18 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Psychiatry and Mental health, 7 papers in Cellular and Molecular Neuroscience and 5 papers in Molecular Biology. Recurrent topics in Sarah E. DeRossett's work include Epilepsy research and treatment (6 papers), Pharmacological Effects and Toxicity Studies (4 papers) and Neuropeptides and Animal Physiology (4 papers). Sarah E. DeRossett is often cited by papers focused on Epilepsy research and treatment (6 papers), Pharmacological Effects and Toxicity Studies (4 papers) and Neuropeptides and Animal Physiology (4 papers). Sarah E. DeRossett collaborates with scholars based in United States, United Kingdom and Spain. Sarah E. DeRossett's co-authors include Stephen G. Holtzman, S G Holtzman, Kevan VanLandingham, Janet Hammond, Richard Bogan, John W. Winkelman, Christina Hill‐Zabala, Markus H. Schmidt, António Gil‐Nagel and Vinay Chaudhry and has published in prestigious journals such as Neurology, Journal of Pharmacology and Experimental Therapeutics and Psychopharmacology.

In The Last Decade

Sarah E. DeRossett

17 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah E. DeRossett United States 12 164 131 115 85 71 18 398
I.M. Donaldson New Zealand 13 163 1.0× 71 0.5× 71 0.6× 174 2.0× 39 0.5× 32 516
Coline L. Lemâle Germany 11 262 1.6× 143 1.1× 87 0.8× 263 3.1× 53 0.7× 20 647
N Gonen Israel 11 79 0.5× 245 1.9× 111 1.0× 82 1.0× 15 0.2× 14 459
Michael J. Cools United States 8 256 1.6× 60 0.5× 176 1.5× 40 0.5× 20 0.3× 26 548
Eun‐Jeung Kang Germany 7 123 0.8× 65 0.5× 52 0.5× 134 1.6× 25 0.4× 8 316
Hsiao‐Lun Ku Taiwan 11 34 0.2× 94 0.7× 86 0.7× 101 1.2× 29 0.4× 18 408
Alberto E. Panerai Italy 8 209 1.3× 107 0.8× 98 0.9× 34 0.4× 50 0.7× 9 512
Timothy D. Fryer United Kingdom 7 120 0.7× 87 0.7× 65 0.6× 126 1.5× 12 0.2× 12 426
Masanobu Ito Japan 11 44 0.3× 74 0.6× 50 0.4× 57 0.7× 28 0.4× 51 358
Renato Galli Italy 12 135 0.8× 296 2.3× 53 0.5× 65 0.8× 105 1.5× 22 532

Countries citing papers authored by Sarah E. DeRossett

Since Specialization
Citations

This map shows the geographic impact of Sarah E. DeRossett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah E. DeRossett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah E. DeRossett more than expected).

Fields of papers citing papers by Sarah E. DeRossett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah E. DeRossett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah E. DeRossett. The network helps show where Sarah E. DeRossett may publish in the future.

Co-authorship network of co-authors of Sarah E. DeRossett

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah E. DeRossett. A scholar is included among the top collaborators of Sarah E. DeRossett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah E. DeRossett. Sarah E. DeRossett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Brodie, Martin J., Jacqueline A. French, Susan A. McDonald, et al.. (2014). Adjunctive use of ezogabine/retigabine with either traditional sodium channel blocking antiepileptic drugs (AEDs) or AEDs with other mechanisms of action: Evaluation of efficacy and tolerability. Epilepsy Research. 108(5). 989–994. 6 indexed citations
3.
Sachdeo, Rajesh, Victor Biton, William E. Rosenfeld, et al.. (2014). A novel design for a dose finding, safety, and drug interaction study of an antiepileptic drug (retigabine) in early clinical development. International Journal of Clinical Pharmacology and Therapeutics. 52(6). 509–518. 8 indexed citations
4.
Biton, Victor, António Gil‐Nagel, Martin J. Brodie, Sarah E. DeRossett, & Virinder Nohria. (2013). Safety and tolerability of different titration rates of retigabine (ezogabine) in patients with partial-onset seizures. Epilepsy Research. 107(1-2). 138–145. 15 indexed citations
5.
Porter, Roger J., David E. Burdette, António Gil‐Nagel, et al.. (2012). Retigabine as adjunctive therapy in adults with partial-onset seizures: Integrated analysis of three pivotal controlled trials. Epilepsy Research. 101(1-2). 103–112. 34 indexed citations
6.
7.
VanLandingham, Kevan, et al.. (2012). An Analysis of the Potential for Suicidality with Ezogabine (Retigabine) (P06.109). Neurology. 78(Meeting Abstracts 1). P06.109–P06.109. 1 indexed citations
8.
Brodie, Matthew A., Jacqueline A. French, Susan A. McDonald, et al.. (2012). Adjunctive Use of Ezogabine/Retigabine with Either Traditional Sodium Channel Blocker or Non-Sodium Channel Blocker Antiepileptic Drugs: Evaluation of Efficacy (P06.097). Neurology. 78(Meeting Abstracts 1). P06.097–P06.097. 1 indexed citations
9.
Winkelman, John W., et al.. (2011). Randomized polysomnography study of gabapentin enacarbil in subjects with restless legs syndrome. Movement Disorders. 26(11). 2065–2072. 54 indexed citations
10.
Landy, Stephen H., Sarah E. DeRossett, Alan M. Rapoport, et al.. (2007). Two double-blind, multicenter, randomized, placebo-controlled, single-dose studies of sumatriptan/naproxen sodium in the acute treatment of migraine: function, productivity, and satisfaction outcomes.. PubMed. 9(2). 53–53. 29 indexed citations
11.
Moloney, Margaret F., et al.. (2006). The Experiences of Midlife Women With Migraines. Journal of Nursing Scholarship. 38(3). 278–285. 21 indexed citations
12.
Chaudhry, Vinay, Thomas O. Crawford, & Sarah E. DeRossett. (1993). Thermal sensitivity in demyelinating neuropathy. Muscle & Nerve. 16(3). 301–306. 22 indexed citations
13.
Baloh, Robert W., Sarah E. DeRossett, T. F. Cloughesy, et al.. (1993). Novel brainstern syndrome associated with prostate carcinoma. Neurology. 43(12). 2591–2591. 21 indexed citations
14.
DeRossett, Sarah E. & S G Holtzman. (1986). Discriminative stimulus effects of the opioid antagonist diprenorphine in the squirrel monkey.. Journal of Pharmacology and Experimental Therapeutics. 237(2). 437–444. 10 indexed citations
15.
DeRossett, Sarah E. & Stephen G. Holtzman. (1985). Effects of opiate antagonists and putative ? agonists on unpunished and punished operant behavior in the rat. Psychopharmacology. 86(4). 386–391. 13 indexed citations
16.
DeRossett, Sarah E. & S G Holtzman. (1984). Effects of naloxone, diprenorphine, buprenorphine and etorphine on unpunished and punished food-reinforced responding in the squirrel monkey.. Journal of Pharmacology and Experimental Therapeutics. 228(3). 669–675. 22 indexed citations
17.
DeRossett, Sarah E. & Stephen G. Holtzman. (1982). Effects of naloxone and diprenorphine on spontaneous activity in rats and mice. Pharmacology Biochemistry and Behavior. 17(2). 347–351. 48 indexed citations
18.
DeRossett, Sarah E., et al.. (1982). Enhanced analgesic response to morphine in adult rats exposed to morphine prenatally. Pharmacology Biochemistry and Behavior. 17(6). 1161–1164. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by I.M. Donaldson Breakdown of academic impact, for papers by Coline L. Lemâle Breakdown of academic impact, for papers by N Gonen Breakdown of academic impact, for papers by Michael J. Cools Breakdown of academic impact, for papers by Eun‐Jeung Kang Breakdown of academic impact, for papers by Hsiao‐Lun Ku Breakdown of academic impact, for papers by Alberto E. Panerai Breakdown of academic impact, for papers by Timothy D. Fryer Breakdown of academic impact, for papers by Masanobu Ito Breakdown of academic impact, for papers by Renato Galli
Rankless by CCL
2026